MEDS Stock Gains 3% Amid Volatile AI Market; Potential Upside Near 200‑Day SMA
MEDS stock rises 3% to $2.72 as investors eye a rebound below its 200‑day SMA, amid volatile AI‑diagnostics market dynamics.
3 minutes to read
DATAMEDS AI INC
Datameds AI (MEDS) Stumbles: 36% Decline Demands Strategic Shift
Datameds AI (MEDS) sees a modest 1.5% uptick but remains 60% below its 200‑day MA, with investors eyeing a strategic pivot for renewed growth.
3 minutes to read